'מערכת אימד'- Abstract
This double-blind, randomized, placebo- and positive-controlled, parallel-group study evaluated the effect of vortioxetine (Lu AA21004), an investigational multimodal antidepressant, on QT interval in accordance with current guidelines of the International Conference on Harmonisation (ICH-E14).
Wang Y, Nomikos GG, Karim A, Munsaka M, Serenko M, Liosatos M, Harris S. Effect of Vortioxetine on Cardiac Repolarization in Healthy Adult Male Subjects: Results of a Thorough QT/QTc Study. Clin Pharmacol Drug Dev. 2013 Oct;2(4):298-309. doi: 10.1002/cpdd.51. Epub 2013 Aug 16. PMID: 27121934.